Precision Optics (NASDAQ:POCI) Stock Crosses Above Two Hundred Day Moving Average - What's Next?

Key Points

• Precision Optics shares rose above their 200-day moving average, reaching $4.65 compared with the $4.63 average, on trading volume of 11,250 shares.
• Analyst sentiment remains negative: Weiss Ratings maintained a “sell” rating, Wall Street Zen upgraded the stock to “hold,” and the overall consensus rating is “Sell.”
• The company beat quarterly expectations, reporting a loss of $0.01 per share versus the expected $0.06 loss and revenue of $8.77 million versus the $7.10 million estimate, though profitability metrics remained negative.

Precision Optics Corp. (NASDAQ:POCI - Get Free Report) shares passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $4.63 and traded as high as $4.65. Precision Optics shares last traded at $4.65, with a volume of 11,250 shares traded.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on POCI shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Precision Optics in a research report on Wednesday, September 2nd. Wall Street Zen upgraded shares of Precision Optics to a "hold" rating in a research report on Saturday, October 3rd. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Precision Optics currently has a consensus rating of "Sell".

Precision Optics Stock Performance

The firm has a market capitalization of $51.10 million, a P/E ratio of -10.11 and a beta of 0.34. The stock has a 50-day moving average of $4.42 and a 200 day moving average of $4.63. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.84 and a current ratio of 2.28.

Precision Optics (NASDAQ:POCI - Get Free Report) last released its quarterly earnings results on Monday, September 28th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.06) by $0.05. The firm had revenue of $8.77 million during the quarter, compared to analysts' expectations of $7.10 million. Precision Optics had a negative return on equity of 23.92% and a negative net margin of 11.51%.

Precision Optics Company Profile

Precision Optics Corporation, Inc is a medical technology company that develops and manufactures advanced optical systems and components for minimally invasive medical procedures. The company works primarily with medical device manufacturers, providing specialized imaging technologies designed to support visualization during surgery and other clinical applications.

Its product portfolio includes rigid and flexible endoscopes, three-dimensional endoscopic systems, disposable and reusable visualization devices, surgical cameras, and custom optical assemblies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.